Estimated Benefit of Dose Reduction to Highly Ventilated Lung Regions for Stage III Non-small Cell Lung Cancer Patients Using Normal Tissue Complication Probability Models

Authors :: Zhang, H. H.
Mohindra, P.
Simone, C. B., II
Bentzen, S. M.
Senan, S.
de Koste, J. R. van Sornsen
Jeudy, J.
D'Souza, W. D.
Radiation Oncology
CCA - Clinical Therapy Development
CCA - Cancer biology and immunology
CCA - Treatment and quality of life
CCA - Cancer immunology
CCA - Evaluation of Cancer Care
Source :: International Journal of Radiation Oncology Biology Physics, 99(2), S109-S109. Elsevier Inc., Zhang, H H, Mohindra, P, Simone, C B II, Bentzen, S M, Senan, S, de Koste, J R V S, Jeudy, J & D'Souza, W D 2017, ' Estimated Benefit of Dose Reduction to Highly Ventilated Lung Regions for Stage III Non-small Cell Lung Cancer Patients Using Normal Tissue Complication Probability Models ', International Journal of Radiation Oncology Biology Physics, vol. 99, no. 2, pp. S109-S109 .
Publication Year :: 2017

Language :: English
ISSN :: 03603016
Database :: OpenAIRE
Journal :: International Journal of Radiation Oncology Biology Physics, 99(2), S109-S109. Elsevier Inc., Zhang, H H, Mohindra, P, Simone, C B II, Bentzen, S M, Senan, S, de Koste, J R V S, Jeudy, J & D'Souza, W D 2017, ' Estimated Benefit of Dose Reduction to Highly Ventilated Lung Regions for Stage III Non-small Cell Lung Cancer Patients Using Normal Tissue Complication Probability Models ', International Journal of Radiation Oncology Biology Physics, vol. 99, no. 2, pp. S109-S109 .
Accession number :: edsair.dedup.wf.001..da3903491cdf04fc4f2634d29e49cf7b

Tools